In this article, Andrew Tepperman discusses a set of specific liability and damages issues that could be addressed by economic and business expert testimony. The context is assumed to be an international arbitration proceeding involving firms in the pharmaceutical industry. This article appeared in the 2015 edition of The International Comparative Legal Guide to: International Arbitration, published by Global Legal Group Ltd, London. To read the article, click the link below.
Q&A with Greg Bell in Power Players: International Arbitration 2023 – Exceptional experts
As scientific advances continue to generate new commercial opportunities, Gregory Bell expects an increase in intercompany collaborations. However, that may...